scispace - formally typeset
E

Enrique Moreno

Researcher at Complutense University of Madrid

Publications -  95
Citations -  2867

Enrique Moreno is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 30, co-authored 95 publications receiving 2683 citations.

Papers
More filters
Journal ArticleDOI

A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention

TL;DR: The use of rifampin may have contributed to homogenizing MSSA and MRSA prognoses, although the specific rifampsin combinations may have had different efficacies.
Journal ArticleDOI

Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation

TL;DR: Oral fluconazole (100 mg) is safe and reduces Candida colonization and infection after liver transplantation, and there was no increased hepatotoxicity, cyclosporine interaction, or emergence of clinically relevant resistant Candida strains attributable to flu Conazole.
Journal ArticleDOI

Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients.

TL;DR: Unrecognized bacteremia in the donor does not have a negative clinical impact on the outcome of organ transplant recipients and there were no documented instances of transmission of the isolated bacteria from the donor to the recipient.
Journal ArticleDOI

Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods.

TL;DR: Investigations using animal models provide useful information for a better understanding of the long-lasting deleterious consequences of cannabis exposure during pregnancy and lactation and chronic administration of cannabinoid agonists during the periadolescent period causes persistent behavioural alterations in adult animals.
Journal ArticleDOI

Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

TL;DR: Although HLA typing is not a prerequisite for transplantation, screening of HLA antibodies with Luminex techniques and CDC crossmatch may be useful in the detection of at‐risk patients that could benefit from increased surveillance and tailored therapy following transplantation.